5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Horizon Two: HR NDMM (MMRC-100)High Risk Newly Diagnosed Multiple MyelomaRecruitingPhase 22026-10-02NCT07053436
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension PeriodHemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, anemia, hematologic disorder, metabolic disease, pyruvate kinase deficiency of red cellsActive, not recruitingPhase 32026-08-27NCT05175105
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of PreventionAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingNot applicable2026-04-06NCT04294927
Forceps vs. Snare IVC Filter RemovalDVTRecruitingNot applicable2026-01-07NCT04092192
Surveillance AFter Extremity Tumor surgerYNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcomaActive, not recruitingNot applicable2024-11-22NCT03944798